[Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux]

Minerva Pediatr. 1991 Dec;43(12):797-800.
[Article in Italian]

Abstract

Fifteen children with gastro-esophageal reflux took part in a treatment trial with a regimen of magnesium hydroxide and aluminium hydroxide for 8 weeks period (700 mmol/1.73 mq/die). All children were evaluated clinically and underwent a 24-hour continuous esophageal pH-monitoring both at diagnosis and after 8 weeks of treatment. After therapy 12/15 children were cured and 3/15 improved. Moreover the total percentage of time during which pH was less than 4, the number of reflux episodes and the number of refluxes lasting than 5' recorded during 24-hour continuous esophageal pH-monitoring were significantly reduced after treatment. The Authors conclude that antacids in large quantities are effective in medical treatment of gastro-esophageal reflux.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract

MeSH terms

  • Aluminum Hydroxide / therapeutic use*
  • Antacids / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Combinations
  • Female
  • Gastroesophageal Reflux / diagnosis
  • Gastroesophageal Reflux / drug therapy*
  • Humans
  • Hydrogen-Ion Concentration
  • Infant
  • Magnesium Hydroxide / therapeutic use*
  • Male
  • Monitoring, Physiologic
  • Time Factors

Substances

  • Antacids
  • Drug Combinations
  • aluminum hydroxide, magnesium hydroxide, drug combination
  • Aluminum Hydroxide
  • Magnesium Hydroxide